{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:18:11Z","timestamp":1793744291204,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Karen Elise Jensen Fonden","award":["2020"],"award-info":[{"award-number":["2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01402-7","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T13:38:43Z","timestamp":1747834723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of 2-Deoxy-D-glucose on glycolytic metabolism in acute myeloblastic leukemic ML-1 cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Nichlas Vous","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne Haahr","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte Bonde","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"8","key":"1402_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells8080805","volume":"8","author":"J Kreitz","year":"2019","unstructured":"Kreitz, J. et al. Metabolic plasticity of acute myeloid leukemia. Cells 8(8), 1\u201328. https:\/\/doi.org\/10.3390\/cells8080805 (2019).","journal-title":"Cells"},{"issue":"SUPPL. 1","key":"1402_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/10245330512331389773","volume":"10","author":"AK Burnett","year":"2005","unstructured":"Burnett, A. K. The treatment of AML: Current status and novel approaches. Hematology 10(SUPPL. 1), 50\u201353. https:\/\/doi.org\/10.1080\/10245330512331389773 (2005).","journal-title":"Hematology"},{"issue":"1","key":"1402_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drup.2012.02.001","volume":"15","author":"BC Shaffer","year":"2012","unstructured":"Shaffer, B. C. et al. Drug resistance: Still a daunting challenge to the successful treatment of AML. Drug Resist. Updates 15(1), 62\u201369. https:\/\/doi.org\/10.1016\/j.drup.2012.02.001 (2012).","journal-title":"Drug Resist. Updates"},{"key":"1402_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051155","author":"IS Gr\u00f8nnings\u00e6ter","year":"2020","unstructured":"Gr\u00f8nnings\u00e6ter, I. S. et al. Targeting cellular metabolism in acute myeloid leukemia and the role of patient heterogeneity. Cells https:\/\/doi.org\/10.3390\/cells9051155 (2020).","journal-title":"Cells"},{"issue":"4","key":"1402_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short, N. J. et al. Advances in the treatment of acute myeloid leukemia: New drugs and new challenges. Cancer Discov. 10(4), 506\u2013525. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1011 (2020).","journal-title":"Cancer Discov."},{"issue":"2","key":"1402_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","volume":"355","author":"D Zhang","year":"2014","unstructured":"Zhang, D. et al. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 355(2), 176\u2013183. https:\/\/doi.org\/10.1016\/j.canlet.2014.09.003 (2014).","journal-title":"Cancer Lett."},{"key":"1402_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010234","author":"B Pajak","year":"2020","unstructured":"Pajak, B. et al. 2-Deoxy-D-glucose and its analogs: From diagnostic to therapeutic agents. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21010234 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1402_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9993386","author":"R Singh","year":"2023","unstructured":"Singh, R., Gupta, V., Kumar, A. & Singh, K. 2-Deoxy-D-glucose: A novel pharmacological agent for killing hypoxic tumor cells, oxygen dependence-lowering in Covid-19, and other pharmacological activities. Adv. Pharmacol. Pharm. Sci. https:\/\/doi.org\/10.1155\/2023\/9993386 (2023).","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"issue":"7","key":"1402_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.bjc.6600547","volume":"87","author":"RL Aft","year":"2002","unstructured":"Aft, R. L., Zhang, F. W. & Gius, D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: Mechanism of cell death. Br. J. Cancer 87(7), 805\u2013812. https:\/\/doi.org\/10.1038\/sj.bjc.6600547 (2002).","journal-title":"Br. J. Cancer"},{"issue":"34","key":"1402_CR10","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano, H., Martin, D. S., Xu, R. H. & Huang, P. Glycolysis inhibition for anticancer treatment. Oncogene 25(34), 4633\u20134646. https:\/\/doi.org\/10.1038\/sj.onc.1209597 (2006).","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"1402_CR11","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.4103\/0973-1482.55138","volume":"5","author":"A Farooque","year":"2009","unstructured":"Farooque, A., Afrin, F., Adhikari, J. S. & Dwarakanath, B. S. Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose. J. Cancer Res. Ther. 5(Suppl 1), S32-5. https:\/\/doi.org\/10.4103\/0973-1482.55138 (2009).","journal-title":"J. Cancer Res. Ther."},{"issue":"19","key":"1402_CR12","doi-asserted-by":"publisher","first-page":"30978","DOI":"10.18632\/oncotarget.16046","volume":"8","author":"L Gu","year":"2017","unstructured":"Gu, L. et al. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia. Oncotarget 8(19), 30978\u201330991. https:\/\/doi.org\/10.18632\/oncotarget.16046 (2017).","journal-title":"Oncotarget"},{"issue":"10","key":"1402_CR13","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1158\/1535-7163.MCT-15-0163","volume":"14","author":"C Larrue","year":"2015","unstructured":"Larrue, C. et al. Antileukemic activity of 2-Deoxy-d-glucose through inhibition of n-linked glycosylation in acute myeloid leukemia with FLT3-ITD or c-KIT mutations. Mol. Cancer Ther. 14(10), 2364\u20132373. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0163 (2015).","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"1402_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12032-020-01394-6","volume":"37","author":"B Lapa","year":"2020","unstructured":"Lapa, B. et al. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target. Med. Oncol. 37(8), 72. https:\/\/doi.org\/10.1007\/s12032-020-01394-6 (2020).","journal-title":"Med. Oncol."},{"issue":"12","key":"1402_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.17354\/cr\/2015\/93","volume":"1","author":"F Muniraj","year":"2015","unstructured":"Muniraj, F. Classification of acute leukemias \u2013 past, present, and future. IJSS Case Rep. Rev. 1(12), 61\u201366. https:\/\/doi.org\/10.17354\/cr\/2015\/93 (2015).","journal-title":"IJSS Case Rep. Rev."},{"issue":"2","key":"1402_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s001090000085","volume":"78","author":"J Sch\u00f6nberger","year":"2000","unstructured":"Sch\u00f6nberger, J. et al. Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78(2), 102\u2013110. https:\/\/doi.org\/10.1007\/s001090000085 (2000).","journal-title":"J Mol Med"},{"issue":"2","key":"1402_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1148\/radiol.2019182391","volume":"291","author":"ZJ Wang","year":"2019","unstructured":"Wang, Z. J. et al. Hyperpolarized 13C MRI: State of the art and future directions. Radiology 291(2), 273\u2013284. https:\/\/doi.org\/10.1148\/radiol.2019182391 (2019).","journal-title":"Radiology"},{"issue":"2","key":"1402_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/nbm.4189","volume":"33","author":"T Harris","year":"2020","unstructured":"Harris, T. et al. Hyperpolarized product selective saturating-excitations for determination of changes in metabolic reaction rates in real-time. NMR Biomed. 33(2), 1\u201315. https:\/\/doi.org\/10.1002\/nbm.4189 (2020).","journal-title":"NMR Biomed."},{"key":"1402_CR19","doi-asserted-by":"publisher","unstructured":"R. L. Hesketh, A. J. Wright, and K. M. Brindle, Innovating metabolic biomarkers for hyperpolarized NMR BT - dynamic hyperpolarized nuclear magnetic resonance, T. Jue and D. Mayer, Eds., Cham: Springer International Publishing, 2021, pp. 151\u2013179. https:\/\/doi.org\/10.1007\/978-3-030-55043-1_7.","DOI":"10.1007\/978-3-030-55043-1_7"},{"issue":"1","key":"1402_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/msb.2010.59","volume":"6","author":"C Vogel","year":"2010","unstructured":"Vogel, C. et al. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol. 6(1), 400. https:\/\/doi.org\/10.1038\/msb.2010.59 (2010).","journal-title":"Mol. Syst. Biol."},{"issue":"3","key":"1402_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1148\/radiology.183.3.1584912","volume":"183","author":"RL Wahl","year":"1992","unstructured":"Wahl, R. L., Henry, C. A. & Ethier, S. P. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 183(3), 643\u2013647. https:\/\/doi.org\/10.1148\/radiology.183.3.1584912 (1992).","journal-title":"Radiology"},{"issue":"1","key":"1402_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/ol.2016.4600","volume":"12","author":"K Song","year":"2016","unstructured":"Song, K. et al. Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia. Oncol. Lett. 12(1), 334\u2013342. https:\/\/doi.org\/10.3892\/ol.2016.4600 (2016).","journal-title":"Oncol. Lett."},{"issue":"5","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3892\/or.2013.2299","volume":"29","author":"H Miwa","year":"2013","unstructured":"Miwa, H. et al. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose. Oncol. Rep. 29(5), 2053\u20132057. https:\/\/doi.org\/10.3892\/or.2013.2299 (2013).","journal-title":"Oncol. Rep."},{"key":"1402_CR24","doi-asserted-by":"publisher","unstructured":"A. Ude, K. Afi-Leslie, K. Okeke, and E. Ogbodo, \u201cTrypan Blue Exclusion Assay, Neutral Red, Acridine Orange and Propidium Iodide,\u201d in Cytotoxicity, A. Sukumaran and M. A. Mansour, Eds., Rijeka: IntechOpen, 2022, ch. 8. https:\/\/doi.org\/10.5772\/intechopen.105699.","DOI":"10.5772\/intechopen.105699"},{"issue":"5","key":"1402_CR25","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1021\/acs.jmedchem.1c01737","volume":"65","author":"YS Wijayasinghe","year":"2022","unstructured":"Wijayasinghe, Y. S. et al. A comprehensive biological and synthetic perspective on 2-Deoxy-d-glucose (2-DG), a sweet molecule with therapeutic and diagnostic potentials. J. Med. Chem. 65(5), 3706\u20133728. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01737 (2022).","journal-title":"J. Med. Chem."},{"issue":"1","key":"1402_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12863-022-01099-x","volume":"23","author":"M Chen","year":"2022","unstructured":"Chen, M., Tao, Y., Yue, P., Guo, F. & Yan, X. Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia. BMC Genom. Data 23(1), 85. https:\/\/doi.org\/10.1186\/s12863-022-01099-x (2022).","journal-title":"BMC Genom. Data"},{"key":"1402_CR27","first-page":"4171","volume":"8","author":"JAM Bastiaansen","year":"1830","unstructured":"Bastiaansen, J. A. M. et al. 2013, \u201cIn vivo enzymatic activity of acetylCoA synthetase in skeletal muscle revealed by 13C turnover from hyperpolarized [1\u201313C]acetate to [1\u201313C]acetylcarnitine\u201d. Biochimica et Biophysica Acta (BBA) General Subjects 8, 4171\u20134178 (1830).","journal-title":"Biochimica et Biophysica Acta (BBA) General Subjects"},{"issue":"4","key":"1402_CR28","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2020200017","volume":"2","author":"R Woitek","year":"2020","unstructured":"Woitek, R. et al. Hyperpolarized 13C MRI of tumor metabolism demonstrates early metabolic response to neoadjuvant chemotherapy in breast cancer. Radiol. Imaging Cancer 2(4), e200017. https:\/\/doi.org\/10.1148\/rycan.2020200017 (2020).","journal-title":"Radiol. Imaging Cancer"},{"issue":"2","key":"1402_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocmr.2024.101095","volume":"26","author":"SH Joergensen","year":"2024","unstructured":"Joergensen, S. H. et al. Hyperpolarized [1-13C]pyruvate cardiovascular magnetic resonance imaging identifies metabolic phenotypes in patients with heart failure. J. Cardiovasc. Magn. Reson. 26(2), 101095. https:\/\/doi.org\/10.1016\/j.jocmr.2024.101095 (2024).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"11","key":"1402_CR30","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/nm1650","volume":"13","author":"SE Day","year":"2007","unstructured":"Day, S. E. et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat. Med. 13(11), 1382\u20131387. https:\/\/doi.org\/10.1038\/nm1650 (2007).","journal-title":"Nat. Med."},{"key":"1402_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00497","author":"E Cavallari","year":"2020","unstructured":"Cavallari, E. et al. In-vitro NMR studies of prostate tumor cell metabolism by means of hyperpolarized [1\u201313C] pyruvate obtained using the PHIP-SAH method. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.00497 (2020).","journal-title":"Front. Oncol."},{"issue":"9","key":"1402_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/nbm.3354","volume":"28","author":"R Sriram","year":"2015","unstructured":"Sriram, R. et al. Real-time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor. NMR Biomed. 28(9), 1141\u20131149. https:\/\/doi.org\/10.1002\/nbm.3354 (2015).","journal-title":"NMR Biomed."},{"issue":"12","key":"1402_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.5264","volume":"37","author":"NV Christensen","year":"2024","unstructured":"Christensen, N. V., Laustsen, C. & Bertelsen, L. B. Differentiating leukemia subtypes based on metabolic signatures using hyperpolarized 13C NMR. NMR Biomed. 37(12), e5264. https:\/\/doi.org\/10.1002\/nbm.5264 (2024).","journal-title":"NMR Biomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01402-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T13:38:44Z","timestamp":1747834724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01402-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17685"}}